Recent studies showed that polymorphisms in the Fat and Obesity-Associated (FTO) gene have robust effects on obesity, obesity-related traits and endophenotypes associated with Alzheimer's disease (AD). This evidence concerns the gene FTO and obesity due to melanocortin 4 receptor deficiency.